glp 1 drugs and gastroparesis New data links GLP-1 agonists for weight loss with higher risk for pancreatitis, GI events Drug-Induced Gastroparesis and Product Liability

35,36 Although some studies report smaller reductions in muscle mass, many scientists argue that these findings should not be ignored due to the high metabolic rate of skeletal muscle which plays an important role in maintaining significant weight loss

Tirzepatide (Zepbound, Mounjaro) This is a dual-agonist medication, meaning it targets both GLP-1 and GIP receptors

doi: 10.1016/J.SURVOPHTHAL.2023.07.002 86 SharmaAParachuriNKumarNSabooBTripathiHNKuppermannBDet al

PATENT CLIFF IMPACT The active ingredient, semaglutide, is the backbone of widely known drugs like Ozempic, Wegovy and Rybelsus by Danish drugmaker Novo Nordisk